QT prolongation risk with antiemetics during COVID 19 treatment
Yükleniyor...
Tarih
2021
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Blackwell Publishing Ltd
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Antiemetics gained an active position in the COVID-19 pandemic as a medical approach to suppressing SARS-CoV-2-induced nausea and vomiting as well as balance side effects from medications in use. Proposed treatments for COVID-19 initiate a concern in regard to the influential impact on cardiotoxicity and prolonged QT intervals. Antiemetic agents pose an additional risk through the prolongations of QT intervals when medication is used concurrently with COVID-19 pharmacological therapies.
Açıklama
Anahtar Kelimeler
Covid-19, QT, Medical
Kaynak
International Journal of Clinical Practice
WoS Q Değeri
Q2
Scopus Q Değeri
Q1
Cilt
75
Sayı
5
